Impact of laughter on air trapping in severe chronic obstructive lung disease
Authors Brutsche MH, Grossman P, Müller RE, Wiegand J, Pello, Baty F, Ruch W
Published 7 March 2008 Volume 2008:3(1) Pages 185—192
Martin H Brutsche1, Paul Grossman2, Rebekka E Müller1, Jan Wiegand1, Pello3, Florent Baty1, Willibald Ruch4
1Pneumology; 2Psycho-Somatic Medicine, University Hospital Basel, Petersgraben, Basel, Switzerland; 3Pello, Clown, Basel, Switzerland; 4Psychology, University of Zurich, Department of Psychology, Zurich, Switzerland
Abstract: Static and dynamic hyperinflation is an important factor of exertional dyspnea in patients with severe COPD. This proof-of-concept intervention trial sought to study whether laughter can reduce hyperinflation through repetitive expiratory efforts in patients with severe COPD. For small groups of patients with severe COPD (n = 19) and healthy controls (n = 10) Pello the clown performed a humor intervention triggering regular laughter. Plethysmography was done before and up to 24 hours after intervention. Laughing and smiling were quantified with video-analysis. Real-time breathing pattern was assessed with the LifeShirt™, and the psychological impact of the intervention was monitored with self-administered questionnaires. The intervention led to a reduction of TLC in COPD (p = 0.04), but not in controls (p = 0.9). TLC reduction was due to a decline of the residual volume. Four (22 [CI 95% 7 to 46] %) patients were ≥10% responders. The frequency of smiling and TLC at baseline were independent predictors of TLC response. The humor intervention improved cheerfulness, but not seriousness nor bad mood. In conclusion, smiling induced by a humor intervention was able to reduce hyperinflation in patients with severe COPD. A smiling-derived breathing technique might complement pursed-lips breathing in patients with symptomatic obstruction.
Keywords: bronchodilator, cheerfulness, COPD, dyspnoea, humor, hyperinflation
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]